As overexpression of ABCB1 is one of the key factors leading to cancer MDR, we next sought to solidify the association of SLC25A40-ABCB1 fusions with resistance to standard of care HGSOC chemotherapeutic agents. The gene discussed is ABCB1; the disease is cancer.